Wave Life Sciences (WVE) Other financing activities (2015 - 2026)
Wave Life Sciences (WVE) posted Other financing activities of $593000.0 for Q1 2026, up 114.1% on a QoQ basis from -$4.2 million in Q4 2025, and up 34.16% year-over-year from $442000.0 in Q1 2025.
Wave Life Sciences (WVE) Other financing activities (2015 - 2026) Analysis & Trends
Wave Life Sciences' Other financing activities history runs 12 years deep, the most recent figure standing at $593000.0 for Q1 2026.
- Quarterly Other financing activities rose 34.16% year-over-year to $593000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (down 66.41% YoY) and the FY2025 annual result came in at $881000.0, down 70.43% from the prior year.
- Other financing activities was $593000.0 for Q1 2026 at Wave Life Sciences, up from -$4.2 million in the prior quarter.
- Across five years, Other financing activities topped out at $13.9 million in Q3 2024 and bottomed at -$11.1 million in Q4 2024.
- A 5-year average of $371533.3 and a median of $349000.0 in 2024 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 4603.57% in 2024, while the deepest fall reached 1873.68% in 2024.
- Wave Life Sciences' Other financing activities stood at $198000.0 in 2022, then surged by 216.67% to $627000.0 in 2023, then slumped by 1873.68% to -$11.1 million in 2024, then soared by 62.19% to -$4.2 million in 2025, then soared by 114.1% to $593000.0 in 2026.
- Business Quant data shows WVE's Other financing activities at $593000.0 in Q1 2026, -$4.2 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 593,000.00 |
| Mar 31, 2026 | 593,000.00 |
| Dec 31, 2025 | -4.21 Mn |
| Dec 31, 2025 | -4.21 Mn |
| Sep 30, 2025 | 2.04 Mn |
| Sep 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 442,000.00 |
| Mar 31, 2025 | 442,000.00 |
| Dec 31, 2024 | -11.12 Mn |
| Dec 31, 2024 | -11.12 Mn |
| Sep 30, 2024 | 13.87 Mn |
| Sep 30, 2024 | 13.87 Mn |
| Jun 30, 2024 | -120,000.00 |
| Jun 30, 2024 | -120,000.00 |
| Mar 31, 2024 | 349,000.00 |
| Mar 31, 2024 | 349,000.00 |
| Dec 31, 2023 | 627,000.00 |
| Dec 31, 2023 | 627,000.00 |